Orginal Article from INSIGHT Health Data Research Hub Diseases affecting the anterior segment, the front part of the eye, are among the leading causes of visual impairment and blindness globally, yet few large-scale datasets have been available for these conditions. In response, clinical researchers at Moorfields Eye Hospital NHS Foundation Trust and University College London…
By Dr Waheeda IllahiBased on Dr Illahi’s talk at the Keratoconus Group AGM For many people living with keratoconus, the focus is understandably on vision: diagnosis, contact lenses, cross-linking, hospital appointments, and trying to manage day-to-day life. But at this year’s AGM, Dr Waheeda Illahi encouraged us to think more broadly about the person behind…
Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, IncisionFree, Topical Drug Therapy for Keratoconus Epioxa Represents a Novel, Groundbreaking Therapy for Patients Afflicted by This Sight-Threatening Rare Disease Epioxa Expected to Be Commercially Available in Q1 2026 Aliso Viejo, CA – October 20, 2025 – Glaukos Corporation (NYSE: GKOS), an…
University of Liverpool researchers receive £2.4 million to advance a minimally invasive treatment for keratoconus, aiming to improve patient access and reduce NHS costs Researchers at the University of Liverpool have secured over £2.4 million in funding to develop a novel, non-invasive treatment for keratoconus, a progressive eye condition that causes the cornea to become…
The National Institute for Health and Care Research (NIHR) have awarded Dr. Shafi Balal a prestigious Doctoral Fellowship at University College London (UCL). The NIHR Doctoral Fellowship is a full-time award that supports individuals to undertake a PhD in an area of research within the NIHR’s remit. The funding will support Dr. Balal in groundbreaking research on using…
At our AGM and Speaker meeting both Dr Abass and optometrist Lynn White, carefully explained the progress of their work to find a solution for those of us who have to cope with not wearing contact lenses for a period of time; yet still need better vision for dealing with basic tasks. Both Ahmed and…
We are pleased to report that Dr Ahmed Abass has published his paper which we are proud to have co-sponsored with Fight for Sight. Dr Abass has kindly provided the following simplified abstract. The full paper can be read here. You can also view his other papers on his University Page here Purpose The study…
University of Liverpool biomedical engineer, Dr. Ahmed Abass, had been awarded funding from Fight for Sight and Keratoconus Group UK to develop a new type of spectacle lens that can correct irregular astigmatism for keratoconus patients. Dr. Abass has now completed the trial and plans to publish his paper later this year and has agreed to present his…